Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Taysha Gene Therapies stock
Learn how to easily invest in Taysha Gene Therapies stock.
Taysha Gene Therapies Inc is a biotechnology business based in the US. Taysha Gene Therapies shares (TSHA) are listed on the NASDAQ and all prices are listed in US Dollars. Taysha Gene Therapies employs 38 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Taysha Gene Therapies
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TSHA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Taysha Gene Therapies stock price (NASDAQ: TSHA)Use our graph to track the performance of TSHA stocks over time.
Taysha Gene Therapies shares at a glance
|Latest market close||$9.53|
|52-week range||$9.00 - $32.39|
|50-day moving average||$13.06|
|200-day moving average||$18.60|
|Wall St. target price||$42.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.81|
Buy Taysha Gene Therapies shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Taysha Gene Therapies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Taysha Gene Therapies price performance over time
|1 week (2022-01-11)||-9.92%|
|1 month (2021-12-17)||-36.55%|
|3 months (2021-10-18)||-44.27%|
|6 months (2021-07-16)||-49.84%|
|1 year (2021-01-15)||-67.78%|
|2 years (2020-01-14)||N/A|
|3 years (2019-01-14)||N/A|
|5 years (2017-01-14)||N/A|
Taysha Gene Therapies financials
|Gross profit TTM||$0|
|Return on assets TTM||-20.76%|
|Return on equity TTM||-47.79%|
|Market capitalisation||$366.7 million|
TTM: trailing 12 months
Taysha Gene Therapies share dividends
We're not expecting Taysha Gene Therapies to pay a dividend over the next 12 months.
Taysha Gene Therapies overview
Taysha Gene Therapies, Inc. , a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-101 for the treatment of GM2 gangliosidosis; TSHA-118 for the treatment of CLN1 disease; and TSHA-102 for the treatment of Rett syndrome. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments; and collaboration with Yale University to advance mini-gene payloads for an AAV gene therapy for the treatment of neurodevelopmental disorders. The company was incorporated in 2019 and is based in Dallas, Texas. .
Taysha Gene Therapies in the news
Taysha Gene Therapies Inc Shares Approach 52-Week Low - Market Mover
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
8 Stocks in Eashwar Krishnan’s Tybourne Capital Management Portfolio
Frequently asked questionsWhat percentage of Taysha Gene Therapies is owned by insiders or institutions?
Currently 30.049% of Taysha Gene Therapies shares are held by insiders and 35.398% by institutions. How many people work for Taysha Gene Therapies?
Latest data suggests 38 work at Taysha Gene Therapies. When does the fiscal year end for Taysha Gene Therapies?
Taysha Gene Therapies's fiscal year ends in December. Where is Taysha Gene Therapies based?
Taysha Gene Therapies's address is: 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 What is Taysha Gene Therapies's ISIN number?
Taysha Gene Therapies's international securities identification number is: US8776191061
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert